News and Events
Dr. Philip Arlen to Speak at Immuno-Oncology Summit - The Summit will return to Boston on - August 28-September 1
Dr. Philip Arlen to Speak at ASCO Annual Meeting - June 2-6, 2017 | McCormick Place | Chicago, IL
May 1-5, 2017 Seaport World Trade Center Boston, MA
Monoclonal Antibodies Targeting Novel Immunogenic Neo-Epitopes for the Treatment of Solid Tumors May 2-4, 2017, Philadelphia Marriott Downtown Philadelphia, PA
Precision Biologics to Highlight Preclinical Data on NEO-201, a Neoantigen Targeting Antibody in Oral Presentation at the 110th Annual Meeting of the American Association of Clinical Research
Rockville, MD, April 2, 2017 – Precision-Biologics Inc.
Dr. Philip Arlen to Speak at Immuno-Oncology Breakthroughs - Novel Cancer Therapies at the Noblecon 13 meeting
Dr. Philip Arlen to Speak at ImmunoTX Summit - The Discovery and Development of Novel Monoclonal Antibodies Targeting Neoantigens 6-7 February 2017, San Diego, USA
Cancer Breakthroughs 2020: The Nation’s First Neoepitope Antibody Immunotherapy Phase II Trial Demonstrating Safety and Prolonged Survival in Patients with Metastatic End-Stage Colon Cancer October 31, 2016
Embed from Getty Images Clinical investigators from Moffitt and Walter Reed Army Institute present data of first Phase II Neoepitope Antibody Immunotherapy Clinical Trial completed at John’s Hopkins, Duke and Moffitt as a potential new immunotherapy treatment for...
Dr. Philip Arlen to Speak at Biomarkers & Precision Medicine USA Congress - 3-4 October 2016, San Diego, USA
Dr. Philip Arlen to Speak at Immune Profiling World Congress – 11-12 October 2016, Fairmont Rey Juan Carlos